ESR Johanna’s latest publication gives insights into the clinical development strategies used to obtain approval for proposed biosimilars and how these have been assessed by the European Medicines Agency.
DIA has designed new elements for DIA Europe 2018 to specifically provide skill development and career support to students and young professionals. Registered young professionals and students will be benefit from the entire DIA Europe 2018 programme, in addition to specialty sessions specifically tailored to address their professional goals.
This year, three IDEAS ESRs had the responsibility of organising the annual International Biometric Society Herbstseminar in Vienna.
In many instances during drug development, question arises “Is it worth proceeding?” This often implies evaluations of “probability of success” (PoS) at a later stage, given the current knowledge.